Moneycontrol PRO

you are here: HomeNewsBusinessStocks'Glenmark to profit from drug price hike, +ve on Sun Pharma'

SHOW NAMES

Trending Topics

business

'Glenmark to profit from drug price hike, +ve on Sun Pharma'

The decision by Taro Pharma, Sun Pharma's Israeli subsidiary, to provide keveyis free of cost to distributors is likely to impact revenues of about USD 25 million, says Praful Bohra, VP Research at Religare.

first published: May 3, 2016 10:39 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347